These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Effect of total parenteral nutrition on liver function. Carpentier YA; Van Brandt M Acta Chir Belg; 1981; 80(2-3):141-4. PubMed ID: 6794269 [TBL] [Abstract][Full Text] [Related]
7. Does long-term home parenteral nutrition in adult patients cause chronic liver disease? Bowyer BA; Fleming CR; Ludwig J; Petz J; McGill DB JPEN J Parenter Enteral Nutr; 1985; 9(1):11-7. PubMed ID: 3918194 [TBL] [Abstract][Full Text] [Related]
8. Demographic and nutritional factors associated with prolonged cholestatic jaundice in the premature infant. Steinbach M; Clark RH; Kelleher AS; Flores C; White R; Chace DH; Spitzer AR; J Perinatol; 2008 Feb; 28(2):129-35. PubMed ID: 18059467 [TBL] [Abstract][Full Text] [Related]
9. [Cholestasis associated with prolonged parenteral nutrition in neonates: the role of urso-deoxycholic acid]. Garzón L; Ledo A; Cubells E; Sáenz P; Vento M An Pediatr (Barc); 2009 Jun; 70(6):547-52. PubMed ID: 19443280 [TBL] [Abstract][Full Text] [Related]
11. [Importance of liver puncture biopsy and endoscopic retrograde cholangiography in patients with chronic anicteric unexplained cholestasis. A retrospective study in 79 patients]. Sapey T; Turlin B; Canva-Delcambre V; Mendler MH; Deugnier Y; Brissot P; Guyader D Gastroenterol Clin Biol; 1999 Feb; 23(2):178-85. PubMed ID: 10353011 [TBL] [Abstract][Full Text] [Related]
12. Similar liver function abnormalities occur in patients receiving glucose-based and lipid-based parenteral nutrition. Wagner WH; Lowry AC; Silberman H Am J Gastroenterol; 1983 Apr; 78(4):199-202. PubMed ID: 6404158 [TBL] [Abstract][Full Text] [Related]
13. Changes in nitrogen metabolism in catabolic patients given three different parenteral nutrition regimens. Tulikoura I; Huikuri K Acta Chir Scand; 1981; 147(7):519-24. PubMed ID: 6808798 [TBL] [Abstract][Full Text] [Related]
14. Hyperbilirubinemia and cholestatic liver injury in hepatitis C-infected liver transplant recipients. Cotler SJ; Taylor SL; Gretch DR; Bronner MP; Rizk R; Perkins JD; Carithers RL Am J Gastroenterol; 2000 Mar; 95(3):753-9. PubMed ID: 10710070 [TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease. Gura KM; Lee S; Valim C; Zhou J; Kim S; Modi BP; Arsenault DA; Strijbosch RA; Lopes S; Duggan C; Puder M Pediatrics; 2008 Mar; 121(3):e678-86. PubMed ID: 18310188 [TBL] [Abstract][Full Text] [Related]
17. Early use of cyclic TPN prevents further deterioration of liver functions for the TPN patients with impaired liver function. Hwang TL; Lue MC; Chen LL Hepatogastroenterology; 2000; 47(35):1347-50. PubMed ID: 11100349 [TBL] [Abstract][Full Text] [Related]
18. Vanishing bile duct syndrome: a possible mechanism for intrahepatic cholestasis in Hodgkin's lymphoma. Hubscher SG; Lumley MA; Elias E Hepatology; 1993 Jan; 17(1):70-7. PubMed ID: 7678577 [TBL] [Abstract][Full Text] [Related]
19. The biochemical and histopathological effects of ursodeoxycholic acid and metronidazole on total parenteral nutrition-associated hepatic dysfunction: an experimental study. Günsar C; Melek M; Karaca I; Sencan A; Mir E; Ortaç R; Canan O Hepatogastroenterology; 2002; 49(44):497-500. PubMed ID: 11995481 [TBL] [Abstract][Full Text] [Related]
20. [Total parenteral nutrition-related cholestatic hepatopathy, is it an infectious disease?]. Beau P; Barrioz T; Ingrand P Gastroenterol Clin Biol; 1994; 18(1):63-7. PubMed ID: 8187992 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]